Treatment of human cancer with adenoviral vector expressing TNF-alpha
A Standard patent application filed on 01 November 2002 credited to Chu, Karen, W.
;
Rasmussen, Henrik, S.
Details
Application number :
2002342263
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Treatment of human cancer with adenoviral vector expressing TNF-alpha
Inventor :
Chu, Karen, W.
;
Rasmussen, Henrik, S.
Agent name :
Pizzeys Patent and Trade Mark Attorneys
Address for service :
Level 20 324 Queen Street Brisbane QLD 4000 Australia
Filing date :
01 November 2002
Associated companies :
Applicant name :
GenVec, Inc
Applicant address :
65 West Watkins Mill Road Gaithersburg MD 20878 United States of America